Quantbot Technologies LP Lowers Position in The Cooper Companies, Inc. (NASDAQ:COO)

Quantbot Technologies LP decreased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 80.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 10,299 shares of the medical device company’s stock after selling 42,048 shares during the period. Quantbot Technologies LP’s holdings in Cooper Companies were worth $947,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Fulton Bank N.A. grew its holdings in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares during the period. Torray Investment Partners LLC grew its stake in Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after acquiring an additional 132 shares during the period. Mather Group LLC. increased its holdings in Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its position in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after acquiring an additional 136 shares during the period. Finally, Greenleaf Trust lifted its holdings in Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on COO. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Piper Sandler restated an “overweight” rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Wells Fargo & Company boosted their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Citigroup decreased their price objective on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Finally, Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Price Performance

COO stock opened at $83.70 on Wednesday. The stock has a market cap of $16.74 billion, a price-to-earnings ratio of 42.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The business has a fifty day moving average of $89.80 and a two-hundred day moving average of $97.72. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.